RGENRepligen Corporation

$7B

Q3 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$50M+35.4% YoY

Gross Profit

$27M55.2% margin

Operating Income

$8M15.9% margin

Net Income

$5M9.7% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+3.8%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$762M

Total Liabilities

$156M

Stockholders' Equity

$606M

Cash & Equivalents

$190M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$37M	+35.4%
Gross Profit	$27M	$17M	+64.8%
Operating Income	$8M	-$406,000	+2042.4%
Net Income	$5M	$5M	+2.7%

Revenue Segments

Product

$50M100%

Royalty

$29,0000%

Geographic Segments

North America

$24M49%

Europe

$19M39%

Asia and Australia

$6M12%

All Other

$62,0000%

RGEN Q3 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena